HeartCare Medical-B (06609) Issues Profit Warning: Expects Interim Net Profit Attributable to Shareholders of No Less Than RMB 40 Million, Marking a Significant Turnaround from Loss

HeartCare-B (06609) announced that the Group expects to achieve a net profit attributable to shareholders of no less than RMB 40 million for the six months ended June 30, 2025, representing a significant turnaround from the net loss attributable to shareholders of approximately RMB 5.1 million for the six months ended June 30, 2024 (the corresponding period). The expected profit and improved performance are mainly due to the business growth of the Group, leading to increased revenue compared to the corresponding period and a decrease in the overall expense ratio of the Group.

The board recommends offsetting its losses by utilizing the company's capital reserve, in accordance with the company’s articles of association and relevant laws and regulations. The loss offset requires approval by the shareholders through an ordinary resolution, and the relevant proposal will be submitted for shareholders' consideration and approval as an ordinary resolution at the company’s second extraordinary general meeting of 2025, to be held on August 29, 2025.